ZCP
PROF

Z3 Capital Partners’s Profound Medical PROF Stock Holding History

Z3 Capital Partners’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.46M Buy
820,941
+2,950
+0.4% +$19.8K 1.15% 26
2026
Q1 		$5.3M Sell
817,991
-950
-0.1% -$6.56K 1.34% 21
2025
Q4 		$6.45M Buy
+818,941
New +$5.26M 1.55% 16

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.59% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
RMC
Ring Mountain Capital Tiburon, California $238M AUM 61.63% 1-Year Est. Return

Z3 Capital Partners's PROF Position: Q2 2026 in Review

Z3 Capital Partners increased its Profound Medical (PROF) stake by 0.36% in Q2 2026, buying an estimated $19.8K and bringing the position to 820,941 shares worth $5.46M. The position accounts for 1.15% of the portfolio, ranked #26.

Z3 Capital Partners first reported a position in PROF in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.45M in Q4 2025. 54 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Z3 Capital Partners held 820,941 shares of Profound Medical worth $5.46M as of Q2 2026.
  • Z3 Capital Partners bought 2,950 Profound Medical shares in Q2 2026, an estimated $19.8K.
  • Profound Medical made up 1.15% of Z3 Capital Partners's portfolio in Q2 2026, its #26 holding.
  • Z3 Capital Partners first reported a position in Profound Medical in Q4 2025 and has held it in 3 quarters since.
  • Z3 Capital Partners's Profound Medical position peaked at $6.45M in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Z3 Capital Partners's 13F filing for Q2 2026, filed 28 Jul 2026.